The Mostoslavsky lab at Harvard & Mass General Cancer Center. We study chromatin, cancer, metabolism, DNA repair, PTMs et al. Tweets are from anyone in the lab!
Really excited to share our new study, where we identified ZNF280A, a novel regulator of homologous recombination during DNA repair, linked to the human 22q11.2 distal deletion syndrome. A special shout out to @ThomasLClarke for leading the project!
nature.com/articles/s41556-0…
We’re happy to share our new study out today @NatureCellBio
We show that a chromatin factor, ZNF280A, is required for DNA double strand break repair, linking its absence to clinical features in 22q11.2 distal deletion syndrome.
@MostoslavskyLabnature.com/articles/s41556-0…
The Mostoslavsky Lab is looking for a highly motivated Research Technician interested in being part of our team for at least two years! Please share with your networks, and/or apply by sending an intro email with CV to: mostoslavskylab@gmail.com
This will be a full-time research technician position, roles will include assisting with basic science techniques, from standard molecular biology to advanced biochemistry, genetics, and in vivo work.
FOR THE LOVE OF PURINES: We are truly excited to share our latest work @CellPressNews on mapping the routes of purine nucleotide synthesis in vivo-De novo and Salvage Purine Synthesis Pathways Across Tissues and Tumors.cell.com/cell/fulltext/S0092…
Thrilled to be a Keynote Speaker at the Center of Excellence in Chromosome Biology (CECB) Symposium in @theNCI. Thanks @WeyemiLab and @LabShalini for the honor!
Online now!! Really thrilled to share our latest work identifying a novel driver of metastasis, Gstt1, @NatureCellBio. A huge effort lead by Christina Ferrer and an incredible team of collaborators!!
link.springer.com/article/10…
Online now!! Really thrilled to share our latest work identifying a novel driver of metastasis, Gstt1, @NatureCellBio. A huge effort lead by Christina Ferrer and an incredible team of collaborators!!
link.springer.com/article/10…
Gstt1, a glutathione conjugase, normally expressed only in the liver, it is specifically upregulated in metastatic cells. Critically, inhibition of Gstt1 does not impact primary tumors, but completely eliminated metastatic growth.
Link to pdf rdcu.be/dKtEA
We found Gstt1 to glutathionylate fibronectin, thus changing the extracellular matrix to allow disseminated tumor cells to survive in the new foreign niche. Inhibiting Gstt1 could be a putative new therapeutic approach against metastases.
I am thrilled and honored to announce that I have been selected (together with the laboratory of Nabeel Bardeesy) as a 2023 Breakthrough Krantz Award recipient! Thank to our teams and the #KrantzCenter for their support and generosity!
massgeneral.org/cancer-cente…#MassGeneral
I am really happy to share that our latest study was published today in Nature Metabolism! We discovered a new way by which cancer cells can adapt to proliferate under glutamine restricted conditions. Amazing work Sam and Tiz!!!! nature.com/articles/s42255-0…
What a thrill! So proud of @YaaAmoh for being selected as a #GilliamFellows! It is such a unique opportunity, for her as a Fellow and for me as a mentor, to engage, network and be inspired by this community. Can't wait for the amazing science you will do as a Fellow. Congrats!!
I’m thrilled to share that I will be joining the Boston University School of Medicine (@BUMedical) as an assistant professor! My lab will officially open on January 1, 2024, in the Department of Pathology and Laboratory Medicine.